SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Invesco QQQ Trust Series 1 - Units of beneficial interest

Market sentiment for the Invesco QQQ Trust is heavily driven by uncertainty regarding a potential U.S. ground invasion in Iran, with traders debating whether escalating geopolitical tensions will lead to a deeper market correction or a short-term relief rally. Investors are actively discussing the impact of rising oil prices on broader inflation, questioning the credibility of ongoing diplomatic efforts, and debating whether current valuations present a buying opportunity or a dangerous bull trap.

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

Market participants are actively debating the impact of volatile geopolitical headlines and contradictory leadership commentary on the escalating conflict in the Middle East, with many traders questioning the reliability of ongoing negotiations and their potential to stabilize energy markets. The conversation is dominated by skepticism regarding policy effectiveness and widespread uncertainty, leading investors to hedge positions while monitoring key technical levels for potential volatility shifts.

Applied Digital Corporation

Applied Digital is currently navigating significant volatility as investors weigh the company's aggressive infrastructure expansion against the broader market's nervousness surrounding Middle East geopolitical instability. While the community remains heavily focused on the upcoming earnings call and potential hyperscaler lease announcements as primary catalysts for a recovery, sentiment is split between those viewing the current price as a long-term accumulation opportunity and those concerned about the company's high debt load in a risk-off macro environment.

Pelican Acquisition Corporation is a special-purpose acquisition company that aims to merge with or acquire businesses, particularly in the global technology sector. The company's primary purpose of facilitate a merger, share exchange, asset acquisition, share purchase, reorganization, or any other form of business combination with one or more businesses.

Greenland Energy Co.

Greenland Energy Co. is experiencing extreme volatility and intense community interest driven by its recent NASDAQ debut and speculative excitement surrounding potential oil drilling rights in Greenland. Investors are actively debating the company's long-term potential as a major energy player versus concerns about it being a high-risk, thin-float momentum play prone to rapid price swings.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is trending as the community debates its long-term potential amid a flurry of partnership activity and active grant applications for DeFi and governance integrations. Investors are actively discussing the protocol's role in AI-native infrastructure, with many debating whether the current price action represents an accumulation phase or a disconnect from broader market sentiment.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil is currently a focal point for investors speculating on energy sector tailwinds as escalating Middle East tensions and potential supply disruptions keep crude oil prices elevated. The community remains deeply divided, with bulls betting on a short squeeze and long-term oil price strength while skeptics highlight concerns regarding the company's fundamentals, recent insider selling, and potential dilution risks.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets, Data Centers, and Treasury and Corporate. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The Treasury and Corporate segment includes the company’s proprietary trading and mining activities, as well as the company’s principal investments and related gains and losses. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

Galaxy Digital is trending as traders speculate on a potential short squeeze, fueled by bullish sentiment in Bitcoin and increasing investor focus on the long-term potential of the company's Helios data center infrastructure. The community is actively debating the company's pivot toward AI-related power demand, while discussions regarding the upcoming delisting from the Canadian exchange and the lack of proactive management updates remain prominent points of contention.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is facing intense volatility as the market reacts to geopolitical tensions involving Iran and uncertainty surrounding the companys upcoming quarterly delivery figures. The community remains deeply divided, with some investors betting on a recovery driven by potential IPO news from SpaceX, while vocal critics continue to focus on the company's valuation, leadership, and the broader risks of a prolonged conflict in the Middle East.

Quantum Computing, Inc. engages in developing novel algorithms and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. It leverages its expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial, security, and government sectors. The company was founded on July 25, 2001 and is headquartered in Hoboken, NJ.

Quantum Computing Inc

Quantum Computing Inc is facing significant market skepticism as investors react to weak organic revenue growth and cooling interest in the quantum sector, leading to ongoing bearish sentiment in the community. While some traders are actively shorting the stock, others are debating whether current valuation levels near cash-on-hand represent a potential entry point for long-term holding.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending after reporting strong Week 40 Phase 3 data, which demonstrates sustained efficacy and positions the company as a potential best-in-class contender in the HS treatment market. The community is actively discussing the potential for a near-term buyout as analyst sentiment shifts, though many investors remain wary of the stock's persistent volatility and institutional market-making patterns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Jyong Biotech Ltd. (NASDAQ:MENS) Short Interest Down 22.7% in March

Jyong Biotech Ltd. (NASDAQ:MENS - Get Free Report) was the target of a significant drop in short interest in March. As of March 13th, there was short interest totaling 288,865 shares, a drop of 22.7...

Jyong Biotech Ltd. (NASDAQ:MENS) Sees Large Decrease in Short Interest

Jyong Biotech Ltd. (NASDAQ:MENS - Get Free Report) saw a large drop in short interest in the month of February. As of February 27th, there was short interest totaling 373,692 shares, a drop of 19.5...

Jyong Biotech (NASDAQ:MENS) Stock Price Down 12.3% - Time to Sell?

Jyong Biotech (NASDAQ:MENS) Shares Down 12.3% - Here's Why...

Jyong Biotech Ltd. (NASDAQ:MENS) Short Interest Update

Jyong Biotech Ltd. (NASDAQ:MENS - Get Free Report) saw a significant increase in short interest during the month of December. As of December 31st, there was short interest totaling 649,057 shares, an...

Jyong Biotech Ltd. (NASDAQ:MENS - Get Free Report) saw a significant increase in short interest in December. As of December 15th, there was short interest totaling 252,374 shares, an increase of...

Jyong Biotech (NASDAQ:MENS) Shares Gap Up - Still a Buy?

Jyong Biotech (NASDAQ:MENS) Shares Gap Up - Time to Buy...

Jyong Biotech (NASDAQ:MENS) Stock Price Down 19.3% - Here's What Happened

Jyong Biotech (NASDAQ:MENS) Shares Down 19.3% - Should You Sell...

Jyong Biotech (NASDAQ:MENS) Trading Down 5.9% - Here's Why

Jyong Biotech (NASDAQ:MENS) Shares Down 5.9% - Here's Why...

Jyong Biotech Ltd.'s (NASDAQ:MENS) Lock-Up Period Will End on December 15th

Jyong Biotech's (NASDAQ:MENS - Get Free Report) lock-up period will expire on Monday, December 15th. Jyong Biotech had issued 2,666,667 shares in its public offering on June 17th. The total size of...

Jyong Biotech (NASDAQ:MENS) Shares Gap Down - Here's Why

Jyong Biotech (NASDAQ:MENS) Shares Gap Down - Here's What Happened...

Jyong Biotech Ltd. operates as a holding company, which engages in the development of biotechnology products. It offers plant-derived drugs that focus on the treatment of urinary system diseases. The company was founded by Fu Feng Kuo in July 2002 and is headquartered in New Taipei, Taiwan.

Jyong Biotech Ltd.

Peloswing

JFDI

ACInvestorBlog

GPaisa

A pillar of the Stocktwits ecosystem. This award recognizes the member who fosters connection, shares invaluable insights, and elevates the daily discussion to empower their fellow traders, on-platform.

Current Price	$1.94
Prev Close	$2.02
Open	$2.00
Dividend Yield	N/A
50-Day Moving Average	$2.24
Beta	6.90
Avg. Volume	439,860.26
PE Ratio	-48.14

52-Week High	$67.00
52-Week Low	$1.43
Market Capitalization	$147.49M
EPS (Annual)	-$0.0407
Price to Book	-6.41
Revenue Per Employee	$0.00

MENS
Jyong Biotech Ltd.

Feed

News

Sentiment

Fundamentals

Info

Latest MENS News

MENSJyong Biotech Ltd.